Drs. Wazni and Gibson do a deep dive on the results of the OPTION Trial answering many of the questions that have come up. December 6, 2024
Dr. Thomas Crawford and Dr. C. Michael Gibson Discuss: Preliminary Results of Randomized Trial of New vs. Reconditioned Pacemakers for Patients Unable to Obtain a New Device in Low- and Middle-Income Countries: The My Heart Your Heart (MHYH) Randomized Trial November 17, 2024 Disclosures: TBD
Dr. Ankeet Bhatt and Dr. C. Michael Gibson Discuss: Electronic Nudges to Increase Influenza Vaccination Among Patients With History of Myocardial Infarction: Insights From 3 Randomized Clinical Trials Enrolling >2 Million Patients (NUDGE-FLU) November 17, 2024 Disclosures: TBD
Dr. Dorairaj Prabhakaran and Dr. C. Michael Gibson Discuss: TOPSPIN- A Three-Arm Randomized Trial for Treatment Optimization of Blood Pressure With Single-Pill Combinations In India November 17, 2024 Disclosures: TBD
Stephan Baldus and Dr. C Michael Gibson Discuss: MATTERHORN: Atrial MR SubgroupTranscatheter Repair Versus Surgery in Atrial Mitral Regurgitation: Results From the MATTERHORN Trial October 30, 2024 Disclosures: TBD
Olivier F Bertrand and Dr. C Michael Gibson Discuss: TARGET IVInternational Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System October 30, 2024 Disclosures: TBD
Expert Roundtable – Vulnerable Plaque, Past, Present and Future October 30, 2024 Disclosure: Sponsored by Cleerly Health
Sanjit S. Jolly and Dr. C Michael Gibson Discuss: CLEAR SYNERGY (OASIS 9)A 2×2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction: The Results of the Colchicine Factorial October 29, 2024 Disclosures: TBD
Dr. David Schnieder and I discuss a new cardiovascular risk marker: Platelet pFCG October 24, 2024 Disclosures: TBD
Dr. Jacob Eifer Møller Presents: Percutaneous Transvalvular Micro-axial Flow Pump In Infarct Related Cardiogenic Shock. Results Of The Danger-shock Trial Slides April 11, 2024 Disclosures: TBD
